Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New non-opioid painkiller Journavx approved by FDA
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
The Boston Globe
3d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller
Journavx
, which the Food and Drug Administration approved on ...
3d
on MSN
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
StudyFinds on MSN
1d
Journavx: What to know about new FDA-approved non-opioid pain medication
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Imposes tariffs on US goods
Antitrust violation probe
Pauses tariffs on Canada, MX
Biden signs with CAA
To block Trump nominees
Taiwanese actress dies at 48
Recall upgraded to Class I
'Special govt. employee'
Winter storm warnings
3 children die in house fire
Team name not changing
Named acting head of CFPB
Garrett requests trade
Aimee Bock stands trial
Protest in Los Angeles
Senate confirms Wright
Highway reopens after fires
2025 'Cowboy Carter' tour
New York shields prescribers
Former Astros coach dies
MLB fires Pat Hoberg
RU energy facilities attacked
UMich sued for protest bans
Fund freeze block extended
Sweden rules out sabotage
On trial over World Cup kiss
DC crash wreckage removal
Martinez refinery fire
Elliott wins Cook Out Clash
Set up joint company
Related topics
FDA
Pain management
Vertex Pharmaceuticals
United States
Food and Drug Administration
Feedback